Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R.

Hum Immunol. 2010 Feb;71(2):212-9. doi: 10.1016/j.humimm.2009.10.009. Epub 2009 Oct 25.

2.

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.

Jackson E, Zhang CX, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, Gilbert L, Bruneau J, Thomas R, Côté P, Trottier B, LeBlanc R, Rouleau D, Tremblay C, Tsoukas CM, Routy JP, Ni X, Mabanga T, Bernard NF; Montreal Primary Infection Study Group.

PLoS One. 2017 Sep 22;12(9):e0185160. doi: 10.1371/journal.pone.0185160. eCollection 2017.

3.

HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis.

Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Shikowitz MJ, Gjertson DW, Reed EF.

Hum Immunol. 2004 Aug;65(8):773-82.

PMID:
15336778
4.

Associations of HLA-DRB1 and -DQB1 alleles with severe recurrent respiratory papillomatosis in Korean patients.

Song EY, Shin S, Park KU, Park MH, Sung MW, Kim KH, Kwon TK.

Hum Immunol. 2013 Aug;74(8):961-4. doi: 10.1016/j.humimm.2013.04.020. Epub 2013 Apr 27.

PMID:
23628399
5.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC.

N Engl J Med. 2012 Aug 30;367(9):805-16. doi: 10.1056/NEJMoa1200503.

6.

The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.

Zwolińska K, Błachowicz O, Tomczyk T, Knysz B, Gąsiorowski J, Zalewska M, Orzechowska BU, Sochocka M, Piasecki E.

Immunogenetics. 2016 May;68(5):327-37. doi: 10.1007/s00251-016-0906-1. Epub 2016 Feb 18.

7.

HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.

Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, Bull P, Bunce M, Welsh K, Marshall SE, Borysiewicz L.

J Virol. 2003 Feb;77(3):1927-39.

8.

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M.

Nat Genet. 2002 Aug;31(4):429-34. Epub 2002 Jul 22.

PMID:
12134147
9.

KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.

Barani S, Khademi B, Ashouri E, Ghaderi A.

Hum Immunol. 2018 Apr;79(4):218-223. doi: 10.1016/j.humimm.2018.01.012. Epub 2018 Feb 9.

PMID:
29408295
10.

A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.

Pontikos N, Smyth DJ, Schuilenburg H, Howson JM, Walker NM, Burren OS, Guo H, Onengut-Gumuscu S, Chen WM, Concannon P, Rich SS, Jayaraman J, Jiang W, Traherne JA, Trowsdale J, Todd JA, Wallace C.

BMC Genomics. 2014 Apr 11;15:274. doi: 10.1186/1471-2164-15-274.

11.

Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.

Misra MK, Prakash S, Moulik NR, Kumar A, Agrawal S.

Hum Immunol. 2016 Jan;77(1):41-46. doi: 10.1016/j.humimm.2015.10.009. Epub 2015 Oct 21.

PMID:
26472014
12.

Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han.

Lu C, Shen YJ, Deng YF, Wang CY, Fan G, Liu YQ, Zhao SM, Zhang BC, Zhao YR, Wang ZE, Zhang CZ, Lu ZM.

Genet Mol Res. 2012 May 15;11(2):1370-8. doi: 10.4238/2012.May.15.7.

13.

Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.

López-Hernández R, Campillo JA, Legaz I, Valdés M, Salama H, Boix F, Hernández-Martínez AM, Eguia J, González-Martínez G, Moya-Quiles MR, Minguela A, García-Alonso A, Carballo F, Muro M.

Microbiol Immunol. 2016 Nov;60(11):787-792. doi: 10.1111/1348-0421.12447.

14.

HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.

Zhao XY, Chang YJ, Xu LP, Zhang XH, Liu KY, Li D, Huang XJ.

Br J Cancer. 2014 Sep 9;111(6):1080-8. doi: 10.1038/bjc.2014.423. Epub 2014 Jul 31.

15.

Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.

James EA, DeVoti JA, Rosenthal DW, Hatam LJ, Steinberg BM, Abramson AL, Kwok WW, Bonagura VR.

J Immunol. 2011 Jun 1;186(11):6633-40. doi: 10.4049/jimmunol.1004181. Epub 2011 Apr 29.

16.

Reduced frequency of two activating KIR genes in patients with sepsis.

Oliveira LM, Portela P, Merzoni J, Lindenau JD, Dias FS, Beppler J, Graebin P, Alho CS, Schwartsmann G, Dal-Pizzol F, Jobim LF, Jobim M, Roesler R.

Hum Immunol. 2017 Apr;78(4):363-369. doi: 10.1016/j.humimm.2017.02.005. Epub 2017 Feb 14.

PMID:
28213050
17.

Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.

Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, You L, Chen ZJ, Li JF, Zhao YR.

J Clin Immunol. 2008 Jul;28(4):343-9. doi: 10.1007/s10875-008-9183-6. Epub 2008 Feb 23.

PMID:
18297378
18.

Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.

Díaz-Peña R, Vidal-Castiñeira JR, Mulero J, Sánchez A, Queiro R, López-Larrea C.

Clin Exp Immunol. 2015 May;180(2):201-6. doi: 10.1111/cei.12568.

19.

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF.

Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695.

PMID:
19630074
20.

Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.

Vineretsky KA, Karagas MR, Christensen BC, Kuriger-Laber JK, Perry AE, Storm CA, Nelson HH.

Cancer Res. 2016 Jan 15;76(2):370-6. doi: 10.1158/0008-5472.CAN-15-0547. Epub 2016 Jan 7.

Supplemental Content

Support Center